CN101611011A - 化合物 - Google Patents

化合物 Download PDF

Info

Publication number
CN101611011A
CN101611011A CNA2007800495252A CN200780049525A CN101611011A CN 101611011 A CN101611011 A CN 101611011A CN A2007800495252 A CNA2007800495252 A CN A2007800495252A CN 200780049525 A CN200780049525 A CN 200780049525A CN 101611011 A CN101611011 A CN 101611011A
Authority
CN
China
Prior art keywords
amino
compound
group
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800495252A
Other languages
English (en)
Chinese (zh)
Inventor
L·达金
K·达利
D·德尔瓦尔
T·格罗
C·A·奥戈
D·斯科特
X·郑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN101611011A publication Critical patent/CN101611011A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2007800495252A 2006-11-10 2007-11-08 化合物 Pending CN101611011A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86524506P 2006-11-10 2006-11-10
US60/865,245 2006-11-10
US60/916,182 2007-05-04

Publications (1)

Publication Number Publication Date
CN101611011A true CN101611011A (zh) 2009-12-23

Family

ID=39627438

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800495252A Pending CN101611011A (zh) 2006-11-10 2007-11-08 化合物

Country Status (4)

Country Link
CN (1) CN101611011A (es)
CL (1) CL2007003220A1 (es)
UY (1) UY30699A1 (es)
ZA (1) ZA200903100B (es)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102584852A (zh) * 2011-12-30 2012-07-18 厦门大学 真菌代谢产物桥南霉素及其制备方法和应用
EP3246028A1 (en) * 2016-05-18 2017-11-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Quinoline compounds for increasing insuline release
CN109730996A (zh) * 2017-03-01 2019-05-10 浙江大学 喹啉结构类型雄激素受体拮抗剂及其应用
WO2021129596A1 (zh) * 2019-12-23 2021-07-01 江苏开元药业有限公司 喹啉类化合物及其应用

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102584852A (zh) * 2011-12-30 2012-07-18 厦门大学 真菌代谢产物桥南霉素及其制备方法和应用
CN102584852B (zh) * 2011-12-30 2014-08-13 厦门大学 真菌代谢产物桥南霉素及其制备方法和应用
EP3246028A1 (en) * 2016-05-18 2017-11-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Quinoline compounds for increasing insuline release
WO2017198756A1 (en) * 2016-05-18 2017-11-23 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Quinoline compounds for increasing insuline release
CN109730996A (zh) * 2017-03-01 2019-05-10 浙江大学 喹啉结构类型雄激素受体拮抗剂及其应用
CN109730996B (zh) * 2017-03-01 2021-08-24 浙江大学 喹啉结构类型雄激素受体拮抗剂及其应用
WO2021129596A1 (zh) * 2019-12-23 2021-07-01 江苏开元药业有限公司 喹啉类化合物及其应用

Also Published As

Publication number Publication date
CL2007003220A1 (es) 2008-05-30
ZA200903100B (en) 2010-04-28
UY30699A1 (es) 2008-07-03

Similar Documents

Publication Publication Date Title
CN107771078B (zh) 用于制备抗癌剂1-((4-(4-氟-2-甲基-1h-吲哚-5-基氧基)-6-甲氧基喹啉-7-基氧基)甲基)环丙胺、其结晶形式和其盐的方法
KR101914720B1 (ko) 암 질환의 치료를 위한 fgfr 키나제 억제제로서의 치환된 벤조피라진 유도체
ES2742409T3 (es) Inhibidores de quinasa de pirazolilquinoxalina
US20090270450A1 (en) Chemical compounds
JP2008502666A (ja) 抗癌剤としての置換キナゾロン類
US20080242663A1 (en) Novel pyrimidine derivatives 698
JP2009532450A (ja) 化合物
JP2008505875A (ja) ホスホチジルイノシトール（ｐｉ）３−キナーゼ阻害剤としての２，４，６−三置換ピリミジンおよび癌の処置におけるそれらの使用
WO2006079791A1 (en) Chemical compounds
CN113773308A (zh) Rho激酶抑制剂
MXPA06014745A (es) Azin-carboxamidas con agente anti-cancer.
JP2009534364A (ja) キナゾリン−４−オン誘導体、それらの製造方法およびそれらを含有する医薬組成物
CN101903385B (zh) 作为组胺h4受体拮抗剂的4-氨基嘧啶衍生物
JP2008511600A (ja) キナゾリン誘導体およびＢ−Ｒａｆ抑制剤としてそれらの使用
CA2693880A1 (en) Pyrimidine derivatives 934
JP2010525047A (ja) 増殖状態の処置のためのＥｐｈＢ４キナーゼ阻害剤としてのＮ’−（フェニル）−Ｎ−（モルホリン−４−イル−ピリジン−２−イル）−ピリミジン−２，４−ジアミン誘導体
JP2009528335A (ja) キナゾリン誘導体
JP2010500988A (ja) ３−シンノリンカルボキサミド誘導体および癌を処置するためのそれらの使用
CN101611011A (zh) 化合物
CN102089286A (zh) 化合物
WO2009010794A1 (en) 2,4-diamino-pyrimidine derivatives
WO2022262691A1 (en) Heterocyclic compounds as sos1 inhibitors
CN101641336A (zh) 3-噌啉甲酰胺衍生物及其治疗癌症的用途
CN111065635B (zh) 作为mth1抑制剂的新型嘧啶衍生物
UA80302C2 (en) Quinazoline derivatives as src tyrosine kinase inhibitors, process for their preparation, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20091223